Algorhythm terminated a prior settlement agreement with Continuation Capital (CCI) regarding $1.93 million in liabilities. Instead of the previous variable share issuance, Algorhythm will now issue a fixed 5 million shares of RIME to CCI to settle the remaining $1.42 million balance, simplifying the debt resolution process.
Algorhythm (RIME) has terminated a previous settlement agreement with Continuation Capital (CCI) concerning $1.93 million in outstanding liabilities. The original agreement involved issuing a variable number of shares until CCI recouped 120% of the claim amount. The new arrangement simplifies this by terminating the prior obligation and instead, Algorhythm will issue a fixed 5 million shares of RIME to CCI to settle the remaining $1.42 million balance. This move provides clarity on the debt resolution for RIME, removing the uncertainty of future share issuances under the old agreement. For CCI, it means a fixed share allocation rather than a performance-based one. The short-term implication for RIME is a clear dilution event with the 5 million share issuance, but it also removes a lingering, potentially larger, dilution risk. Traders should monitor the market's reaction to this fixed dilution versus the previous open-ended commitment.